IMOS [CHIPMOS TECHNOLOGIES BERMUDA] 20-F/A: EXPLANATORY NOTE This Form 20-F/A is being filed

[EXPLANATORY NOTE This Form 20-F/A is being filed in response to a comment letter from the staff of the SEC to the Company dated December 16, 2014 (the “SEC Comment Letter”). We expect that the SEC Comment Letter and our response letter will be released in due course on the SEC’s Electronic Data Gathering, Analysis, and Retrieval (EDGAR) system at] [CERTIFICATIONS I, Shih-Jye Cheng, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based] [CERTIFICATIONS I, Shou-Kang Chen, certify that: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based] [ChipMOS TECHNOLOGIES (Bermuda) LTD. CERTIFICATION Shih-Jye Cheng Chairman and Chief Executive Officer EX-13.1 4 d839261dex131.htm EX-13.1] [ChipMOS TECHNOLOGIES (Bermuda) LTD. CERTIFICATION Shou-Kang Chen Chief Financial Officer EX-13.2 5 d839261dex132.htm EX-13.2] [December 31, 2014 The Board of Directors ChipMOS TECHNOLOGIES (Bermuda) LTD. No. 1, R & D Road 1 Hsinchu Science Park Hsinchu City, 30076 Republic of China Mr. S.J. Cheng Attention: Dear Sirs, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT Yours faithfully, Certified Public Accountants Hong Kong EX-15.1 6 d839261dex151.htm EX-15.1]

By | 2016-03-17T14:25:38+00:00 December 31st, 2014|Categories: Chinese Stocks, IMOS, Webplus ver|Tags: , , , , , |0 Comments

NPD [China Nepstar Chain Drugstore] 6-K: (Original Filing)

[China Nepstar Chain Drugstore Announces $5 Million Share Repurchase Program SHENZHEN, China, December 30, 2014 -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced that the Company’s Board of Directors has authorized a share repurchase program (the “Share Repurchase Program”).] [FORM 6-K Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. th 6 Nanhai Road, Nanshan District. Shenzhen Guangdong Province 518054 People’s Republic of China x ¨ Form 20-F ¨ x Yes ¨ x Yes Number Description of Document 99.1 Press Release CHINA NEPSTAR CHAIN DRUGSTORE LTD.]

By | 2016-03-30T08:58:31+00:00 December 31st, 2014|Categories: Chinese Stocks, NPD, SEC Original|Tags: , , , , , |0 Comments

NPD [China Nepstar Chain Drugstore] 6-K: China Nepstar Chain Drugstore Announces $5 Million Share

[China Nepstar Chain Drugstore Announces $5 Million Share Repurchase Program SHENZHEN, China, December 30, 2014 -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, today announced that the Company’s Board of Directors has authorized a share repurchase program (the “Share Repurchase Program”).] [FORM 6-K Commission Filing Number: 001-33751 CHINA NEPSTAR CHAIN DRUGSTORE LTD. th 6 Nanhai Road, Nanshan District. Shenzhen Guangdong Province 518054 People’s Republic of China x ¨ Form 20-F ¨ x Yes ¨ x Yes Number Description of Document 99.1 Press Release CHINA NEPSTAR CHAIN DRUGSTORE LTD.]

By | 2016-03-30T08:59:25+00:00 December 31st, 2014|Categories: Chinese Stocks, NPD, Webplus ver|Tags: , , , , , |0 Comments

SGOC [SGOCO] 6-K: (Original Filing)

[SGOCO Group, Ltd. Announces Sale of SGOCO (Fujian) Electronic Co., Ltd Hong Kong, December 31, 2014 - SGOCO Group, Ltd. (Nasdaq: SGOC) (“SGOCO” or the “Company”), a company focused on product design, distribution and brand development in display products, today announced the sale of 100% of the equity of SGOCO (Fujian) Electronic Co., Ltd (“Sgoco Fujian”), a company registered in] []

TPI [TIANYIN PHARMACEUTICAL] 10-Q: (Original Filing)

[] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q0914ex32i_tianyinpharma.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director EX-32.2 5 f10q0914ex32ii_tianyinpharma.htm CERTIFICATION]

By | 2016-03-19T15:04:02+00:00 December 31st, 2014|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

SGOC [SGOCO] 6-K: SGOCO Group, Ltd. Announces Sale of SGOCO (Fujian)

[SGOCO Group, Ltd. Announces Sale of SGOCO (Fujian) Electronic Co., Ltd Hong Kong, December 31, 2014 - SGOCO Group, Ltd. (Nasdaq: SGOC) (“SGOCO” or the “Company”), a company focused on product design, distribution and brand development in display products, today announced the sale of 100% of the equity of SGOCO (Fujian) Electronic Co., Ltd (“Sgoco Fujian”), a company registered in] []

TPI [TIANYIN PHARMACEUTICAL] 10-Q:

[] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q0914ex32i_tianyinpharma.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director EX-32.2 5 f10q0914ex32ii_tianyinpharma.htm CERTIFICATION]

By | 2016-03-19T15:04:55+00:00 December 31st, 2014|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar